Dynavax's adult hepatitis B vaccine HEPLISAV-B is currently marketed in the US and is differentiated by its two-dose regimen over one month, which enables high levels of seroprotection faster than ...
An estimated 1m Uyghurs and other ethnic minorities were detained in “re-education” camps during a security crackdown in China from 2017 to 2019.